Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Assembly Biosciences Inc (NASDAQ:ASMB)

30.49
Delayed Data
As of Sep 20
 -0.43 / -1.39%
Today’s Change
6.74
Today|||52-Week Range
31.90
+150.95%
Year-to-Date
New Strong Sell Stocks for September 18th
Sep 18 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close30.92
Today’s open30.95
Day’s range30.12 - 31.90
Volume126,843
Average volume (3 months)96,646
Market cap$536.9M
Dividend yield--
Data as of 09/20/2017

Growth & Valuation

Earnings growth (last year)-41.99%
Earnings growth (this year)-32.30%
Earnings growth (next 5 years)-15.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book6.68

Competitors

 Today’s
change
Today’s
% change
KPTIKaryopharm Therapeut...+0.64+6.08%
CMTAClementia Pharmaceut...+0.04+0.24%
ZEALZealand Pharma A/S-0.07-0.37%
ABEOAbeona Therapeutics ...-0.25-1.49%
Data as of 09/20/2017

Financials

Next reporting dateNovember 8, 2017
EPS forecast (this quarter)-$0.88
Annual revenue (last year)$0.00
Annual profit (last year)-$44.3M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Derek A. Small
CFO, COO &
Principal Accounting Officer
David J. Barrett
Corporate headquarters
Carmel, Indiana

Forecasts